Cord blood S100B protein in growth-restricted newborns
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Women’s health & pregnancy clinical trials.
This study measures a protein called S100B in umbilical cord blood to learn more about brain development in newborns with fetal growth restriction (FGR), a condition where a baby is smaller than expected. Understanding this protein could help doctors identify babies who may need extra support after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 37 weeks pregnant with a single baby (not twins or more).
- Your pregnancy must be complicated by fetal growth restriction (your baby is smaller than expected).
- You cannot smoke or use illegal drugs.
- You cannot have had diabetes before becoming pregnant.
- You cannot have depression that requires medication.
- The amniotic sac cannot have been broken for more than 15 hours, and labor cannot last longer than 15 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures a protein (S100B) in cord blood from babies who had or did not need a blood transfusion in the womb for hemolytic disease. It looks for possible markers of brain health.
This study tests whether melatonin (a natural sleep hormone) can help babies who are not growing well in the womb due to placental blood-flow problems. Researchers will measure if melatonin improves the baby's growth and health before delivery.
This study uses a special type of MRI (magnetic resonance imaging) to look at the brain development of babies who are growing slowly in the womb. The goal is to see if this scan can help doctors better understand this condition and how to care for these babies.
This study looks at two substances in the blood from the umbilical cord (IL-6 and lactate) to see if they can help doctors understand how well a newborn is doing after birth.
This study follows women whose babies have a growth problem in the womb (FGR) linked to how blood flows to the placenta. It looks at causes and outcomes to help improve care.
This study uses ultrasound to look at blood flow patterns in the heart and major blood vessels of babies who are smaller than expected (fetal growth restriction). It will compare these patterns to those in normally growing babies to see how they change as other growth measurements change.
Hear when a new Hypoxia-Ischemia, Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.